
Loading, please wait...

Loading, please wait...

Premature ovarian insufficiency (POI) remains a leading cause of infertility, affecting women before age 40. Recently, researchers have identified KAT2A in ovarian dysfunction as a critical driver of this condition. Lysine acetyltransferase 2A (KAT2A) typically maintains genome stability, but its overexpression appears to accelerate reproductive aging significantly.
Studies show that KAT2A levels increase in human granulosa cells isolated from POI patients. Furthermore, this upregulation activates the p38/MAPK signaling pathway within the ovarian environment. This activation triggers cellular apoptosis and increases the production of reactive oxygen species (ROS). Consequently, the ovaries suffer from follicular atresia and a significantly diminished ovarian reserve.
The research utilized mouse models to demonstrate the impact of elevated KAT2A levels. Mice with KAT2A overexpression showed irregular estrous cycles and severe hormonal imbalances. Additionally, these mice experienced follicular development disorders and increased atresia. However, the use of a specific p38/MAPK inhibitor effectively reversed many of these negative effects. Therefore, the KAT2A-p38/MAPK axis represents a vital molecular network in POI pathogenesis.
Clinicians currently lack effective disease-modifying therapies for POI. Most current treatments focus on hormone replacement therapy rather than addressing underlying cellular death. Thus, targeting KAT2A could provide a novel approach to preserving fertility in aging women. Future research may focus on clinical applications of p38/MAPK inhibitors to mitigate ovarian aging.
KAT2A overexpression triggers the p38/MAPK pathway, which causes granulosa cell death. Since these cells support oocyte development, their loss leads to premature ovarian failure and infertility.
Preclinical studies suggest that inhibiting the p38/MAPK pathway can mitigate the damage caused by KAT2A. This discovery opens doors for developing targeted therapies for women at risk of POI.
Common signs include irregular periods, hot flashes, and difficulty conceiving. Early diagnosis is essential for exploring various fertility preservation options.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A new study reveals that KAT2A overexpression drives premature ovarian insufficiency by activating the p38/MAPK signaling pathway in granulosa cells....
8 months ago

The randomized HOBIT-AF trial reveals that while structured weight loss after catheter ablation significantly improves cardiometabolic health in obese patients with paroxysmal atrial fibrillation, it does not reduce arrhythmia recurrence compared to standard care.
Today

Delhi is undergoing a major healthcare overhaul with enhanced Ayushman Bharat insurance up to ₹10 lakh, increased MBBS and PG medical training seats, expanded primary network mandirs, new tertiary neuro-ICUs, and public-private reproductive technology initiatives to build a resilient, preventative healthcare model.
Today

Aon forecasts India's healthcare inflation will ease to 10.1% in 2027 from 11.5% in 2026. Despite moderation, healthcare expenses continue to outpace general inflation, propelled by non-communicable diseases, advanced medical therapeutics, and expanding utilization patterns across diverse patient populations.
Today

Non-union fractures occur in 2-5% of cases, causing significant disability and cost. Conservative modalities such as LIPUS, PEMF, and focused ESWT offer non-surgical healing options for defects up to 5-10 mm when adequate mechanical stability exists without infection.
Yesterday

A crossover trial reveals that acute resistance exercise at 80% 1RM markedly reduces circulating asprosin, enhances insulin sensitivity, and blunts appetite in women with and without obesity, establishing high-intensity lifting as an effective non-pharmacological metabolic therapy.
Today